Yusimry Drug Interactions: 241 Major, 860 Moderate
Yusimry (Adalimumab-Aqvh) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Yusimry. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Adalimumab is combined with Abacavir.
Level 2 evidence
Abatacept
The risk or severity of infection can be increased when Adalimumab is combined with Abatacept.
Level 1 evidence
Abiraterone
The risk or severity of liver damage can be increased when Adalimumab is combined with Abiraterone.
Level 2 evidence
Abrocitinib
The metabolism of Abrocitinib can be increased when combined with Adalimumab.
Level 1 evidence
Acamprosate
The risk or severity of liver damage can be increased when Adalimumab is combined with Acamprosate.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Adalimumab is combined with Acarbose.
Level 2 evidence
Acebutolol
The metabolism of Acebutolol can be increased when combined with Adalimumab.
Level 1 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Adalimumab is combined with Aceclofenac.
Level 2 evidence
Acetaminophen
The metabolism of Acetaminophen can be increased when combined with Adalimumab.
Level 1 evidence
Acetazolamide
The risk or severity of liver damage can be increased when Adalimumab is combined with Acetazolamide.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Adalimumab is combined with Acetohydroxamic acid.
Level 2 evidence
Acetylsalicylic acid
The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab.
Level 1 evidence
Enter your NPI to unlock 18 major interactions for Yusimry
Yusimry (Adalimumab-Aqvh) has 1222 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Yusimry (Adalimumab-Aqvh) has 241 major, 860 moderate, and 121 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Yusimry. Always confirm against the full prescribing information.